Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse MKT  >  IGI LABORIGI       

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2015 42,9 M
EBIT 2015 0,63 M
Net income 2015 4,35 M
Debt 2015 12,8 M
Yield 2015 -
Sales 2016 77,0 M
EBIT 2016 13,5 M
Net income 2016 1,09 M
Debt 2016 40,5 M
Yield 2016 -
P/E ratio 2015 174,86
P/E ratio 2016 218,57
EV / Sales 2015 7,85x
EV / Sales 2016 4,73x
Capitalization 324 M
More Financials
Company
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products... 
Sector
Pharmaceuticals
Calendar
03/01Earnings Release
More about the company
Surperformance© ratings of IGI LABORIGI
Trading Rating : Investor Rating :
More Ratings
Latest news on IGI LABORIGI
02/02 TELIGENT : Announces FDA Approval Of Lidocaine Ointment USP 5%
01/11 TELIGENT : To Present At 34th Annual J.P. Morgan Healthcare Conference On Januar..
2015 TELIGENT : Announces Fourteenth & Fifteenth ANDA Submissions Of 2015
2015 TELIGENT : Announces Submission of Two Topical ANDAs
2015 TELIGENT : Entry into a Material Definitive Agreement, Completion of Acquisition..
2015 TELIGENT : Added To NASDAQ Biotechnology Index (NBI)
2015 TELIGENT : Announces FDA Approval Of CEFOTAN® (cefotetan) For Injection
2015 TELIGENT : Entry into a Material Definitive Agreement, Financial Statements and ..
More news
Sector news : Pharmaceuticals - NEC
02/13 NOVO NORDISK A/S : Proposed changes in composition of the Board of Directors of ..
02/12 AMGEN : Mystery cannabis 'consortium' reportedly interested in Longmont's Amgen ..
02/12DJSHIRE : Files 8K - Other Events
More sector news : Pharmaceuticals - NEC
Comments 
Advertisement
Chart IGI LABORIGI
Duration : Period :
IGI LABORIGI Technical Analysis Chart | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions